These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 8995712

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The role of protein traffic in the progression of renal diseases.
    Ruggenenti P, Remuzzi G.
    Annu Rev Med; 2000; 51():315-27. PubMed ID: 10774467
    [Abstract] [Full Text] [Related]

  • 3. How renal cytokines and growth factors contribute to renal disease progression.
    Benigni A, Remuzzi G.
    Am J Kidney Dis; 2001 Jan; 37(1 Suppl 2):S21-4. PubMed ID: 11158856
    [Abstract] [Full Text] [Related]

  • 4. Endothelin antagonists and renal protection.
    Benigni A, Perico N, Remuzzi G.
    J Cardiovasc Pharmacol; 2000 Jan; 35(4 Suppl 2):S75-78. PubMed ID: 10976787
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Glomerular protein trafficking and progression of renal disease to terminal uremia.
    Benigni A, Remuzzi G.
    Semin Nephrol; 1996 May; 16(3):151-9. PubMed ID: 8734458
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Progression of renal injury toward interstitial inflammation and glomerular sclerosis is dependent on abnormal protein filtration.
    Zoja C, Abbate M, Remuzzi G.
    Nephrol Dial Transplant; 2015 May; 30(5):706-12. PubMed ID: 25087196
    [Abstract] [Full Text] [Related]

  • 12. Chronic renal diseases: renoprotective benefits of renin-angiotensin system inhibition.
    Remuzzi G, Ruggenenti P, Perico N.
    Ann Intern Med; 2002 Apr 16; 136(8):604-15. PubMed ID: 11955029
    [Abstract] [Full Text] [Related]

  • 13. Cellular responses to protein overload: key event in renal disease progression.
    Zoja C, Benigni A, Remuzzi G.
    Curr Opin Nephrol Hypertens; 2004 Jan 16; 13(1):31-7. PubMed ID: 15090857
    [Abstract] [Full Text] [Related]

  • 14. Time course and localization of endothelin-1 gene expression in a model of renal disease progression.
    Bruzzi I, Corna D, Zoja C, Orisio S, Schiffrin EL, Cavallotti D, Remuzzi G, Benigni A.
    Am J Pathol; 1997 Nov 16; 151(5):1241-7. PubMed ID: 9358749
    [Abstract] [Full Text] [Related]

  • 15. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia).
    Lancet; 1997 Jun 28; 349(9069):1857-63. PubMed ID: 9217756
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Protein traffic activates NF-kB gene signaling and promotes MCP-1-dependent interstitial inflammation.
    Donadelli R, Abbate M, Zanchi C, Corna D, Tomasoni S, Benigni A, Remuzzi G, Zoja C.
    Am J Kidney Dis; 2000 Dec 28; 36(6):1226-41. PubMed ID: 11096048
    [Abstract] [Full Text] [Related]

  • 20. Urine excretion of protein HC in proteinuric glomerular diseases correlates to urine IgG but not to albuminuria.
    Bakoush O, Grubb A, Rippe B, Tencer J.
    Kidney Int; 2001 Nov 28; 60(5):1904-9. PubMed ID: 11703609
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.